ArticleThe journal of pathology. Clinical research2024

Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.

Tamás László et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.